Si has stated Adult EAP survival figures over 60% compared to Rux 20-30% survival. This is using Ryoncil not Prochymal
Also on the record saying trial costs under $10 million, someone posted a BP report with quoted costs top range of 9 million.
60- 70 patients per control arm - access to CIBMTR network speeds up recruitment.
Reg
Ann: Half Year Financial Results Presentation, page-63
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.030(3.19%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 98.0¢ | 92.0¢ | $3.342M | 3.477M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33313 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 73982 | 2 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |